Oliver Luxxe Assets’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,137
Closed -$3.3M 208
2025
Q4
$3.3M Sell
31,137
-26,145
-46% -$3.03M 0.5% 65
2025
Q3
$7.28M Sell
57,282
-7,820
-12% -$931K 1.15% 26
2025
Q2
$7.98M Buy
65,102
+689
+1% +$78.7K 1.42% 12
2025
Q1
$6.52M Sell
64,413
-59,593
-48% -$5.82M 1.21% 20
2024
Q4
$11.7M Buy
124,006
+63,453
+105% +$6.23M 1.04% 27
2024
Q3
$5.85M Buy
60,553
+18,407
+44% +$1.65M 1.05% 29
2024
Q2
$3.62M Buy
42,146
+564
+1% +$47.3K 0.77% 49
2024
Q1
$3.43M Buy
41,582
+348
+0.8% +$25.5K 0.72% 55
2023
Q4
$2.75M Sell
41,234
-3,262
-7% -$211K 0.65% 57
2023
Q3
$2.99M Buy
44,496
+25,235
+131% +$1.74M 0.77% 45
2023
Q2
$1.3M Buy
19,261
+540
+3% +$33.8K 0.33% 83
2023
Q1
$1.01M Buy
18,721
+9,723
+108% +$566K 0.27% 86
2022
Q4
$538K Buy
+8,998
New +$489K 0.15% 126
2019
Q1
Sell
-4,508
Closed -$221K 118
2018
Q4
$221K Sell
4,508
-91
-2% -$5.18K 0.15% 95
2018
Q3
$281K Buy
+4,599
New +$280K 0.16% 88

Other funds holding EHC

Oliver Luxxe Assets's EHC Position: Q1 2026 in Review

Oliver Luxxe Assets sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 31,137 shares — an estimated $3.3M sold.

Oliver Luxxe Assets first reported a position in EHC in Q3 2018 and held it in 15 quarters. The position peaked at $11.7M in Q4 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Oliver Luxxe Assets reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Oliver Luxxe Assets sold 31,137 Encompass Health shares in Q1 2026, an estimated $3.3M.
  • Oliver Luxxe Assets first reported a position in Encompass Health in Q3 2018 and held it in 15 quarters.
  • Oliver Luxxe Assets's Encompass Health position peaked at $11.7M in Q4 2024.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Oliver Luxxe Assets's 13F filing for Q1 2026, filed 8 Apr 2026.